Dr. Frank V Coco, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 99 Lincoln St, Framingham, MA 01702 Phone: 508-383-1000 Fax: 508-383-8584 |
Rasmia Aftab Ahmed, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 571 Union Ave Ste 202, Framingham, MA 01702 Phone: 508-665-6261 Fax: 086-654-1755 |
Venu Gopal Bathini, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 571 Union Ave Ste 202, Framingham, MA 01702 Phone: 508-665-6261 Fax: 508-665-4175 |
Kala Seetharaman, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 115 Lincoln St, Framingham, MA 01702 Phone: 508-383-1000 Fax: 508-383-8584 |
Dr. Husein Q Campwala, MD Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 99 Lincoln St, Framingham, MA 01702 Phone: 508-383-8510 |
News Archive
King Pharmaceuticals®, Inc. and Pain Therapeutics®, Inc. today announced that King has resubmitted a New Drug Application for REMOXY® to the U.S. Food and Drug Administration in response to a Complete Response letter received by Pain Therapeutics in December 2008.
A new study recently published on the medRxiv* preprint server demonstrates the use of a serological testing algorithm for identifying disparities in infection rates and vaccine uptake amongst the study population to enable public health interventions.
Soligenix, Inc., a late-stage biopharmaceutical company, announced today its financial results for the second quarter of 2011.
Urine LAM-ELISA does not appear to be useful as an independent diagnostic test for pulmonary tuberculosis (TB). A trial of the new diagnostic, described in the open access journal BMC Infectious Diseases found that it was only capable of identifying 50.7% of TB cases.
› Verified 3 days ago